Clinical Trials Directory

Trials / Unknown

UnknownNCT00584610

The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots

The Effect of a Levonorgestrel-releasing Intrauterine Device Versus a Copper Containing Intrauterine Device on Coagulation Parameters

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Vermont · Academic / Other
Sex
Female
Age
18 Years – 52 Years
Healthy volunteers
Accepted

Summary

This is a randomized controlled trial to assess the effect of a levonorgesterel-releasing intrauterine device (LNG IUD, Mirena®) versus a copper IUD (Paraguard®) on coagulation parameters known to be associated with risk of thrombosis (blood clots). Both the LNG IUD and the copper IUD are FDA approved devices for contraception. Women enrolled in this study will be randomized to receive either the LNG IUD or the copper IUD. They will complete a one month bleeding diary prior to insertion of the IUD and again for one month while the IUD is in place. They will undergo phlebotomy (blood draw) at baseline (prior to insertion of the IUD), two and four months. Stored samples will be used to measure D-dimer, C-reactive protein (CRP), antithrombin (AT), factor VIIIc, activated partial thromboplastin time (aPTT) and activated partial thromboplastin time plus activated protein C (aPTT + APC). Both groups will undergo a GYN exam with screening for bacterial vaginosis and gonorrhea/chlamydia cultures prior to insertion of the IUD. A brief survey to assess the women's experience with the IUD, including symptomatology and satisfaction with the device, will be conducted at the four months after insertion.

Conditions

Interventions

TypeNameDescription
DEVICELevonorgestrel-containing IUD (Mirena®)Levonorgestrel-containing intrauterine device insertion
DEVICECopper-containing IUD (Paraguard®)Copper-containing intrauterine device insertion

Timeline

Start date
2007-12-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2008-01-02
Last updated
2010-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00584610. Inclusion in this directory is not an endorsement.